Literature DB >> 10397153

Unique features of SHIP, SHP-1 and SHP-2 binding to FcgammaRIIb revealed by surface plasmon resonance analysis.

S J Famiglietti1, K Nakamura, J C Cambier.   

Abstract

A growing family of inhibitory receptors characterized by content of one or more immunoreceptor tyrosine-based inhibitor motif (ITIM), I/V xYxxL/V, has been shown to regulate activation and effector function of immune system cells. The inhibitory activity of these receptors is mediated in large part by tyrosyl phosphorylated ITIM (pITIM) interactions with cytoplasmic effectors. Interestingly, different members of the family utilize partially distinct subsets of effectors from a group that includes SHP-1, SHP-2 and SHIP, an inositol 5' phosphatase. For example, while killer inhibitory receptors bind only SHP-1 and SHP-2, FcgammaRIIB bind SHIP, SHP-1 and SHP-2. The basis of selectivity of ITIMs for effectors is unclear. In this study surface plasmon resonance has been used to characterize the binding of phosphorylated FcgammaRIIB ITIM peptides to SHP-1, SHP-2 and SHIP derived Src-homology 2 (SH2) domains. SHIP was found to bind with highest affinity with intermediate on and off rates. SHP-1 bound with lowest affinity with slow on and slow off kinetics, and only its C-terminal SH2 domain exhibited binding activity. Both C- and N-terminal SH-2 domains of SHP-2 bound the pITIM. The affinity of these interactions were similar, however, they exhibited relatively fast on fast off and slow on slow off kinetics respectively. Interestingly, removal of the Ala-Glu-Asn sequence which lies immediately N-terminal from the ITIM in FcR ablated binding to SHP-1 and SHP-2 but not to SHIP. These results reveal a previously unrecognized level of complexity of effector binding to pITIM, including dependence of optimal SHP-1 and SHP-2 binding on residues N-terminal from the ITIM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397153     DOI: 10.1016/s0165-2478(99)00027-9

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

Review 1.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

Review 2.  The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.

Authors:  Paul M Waterman; John C Cambier
Journal:  FEBS Lett       Date:  2010-09-28       Impact factor: 4.124

Review 3.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

4.  Visualization of negative signaling in B cells by quantitative confocal microscopy.

Authors:  H Phee; W Rodgers; K M Coggeshall
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 5.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

6.  Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19.

Authors:  Dániel Szili; Marcell Cserhalmi; Zsuzsanna Bankó; György Nagy; David E Szymkowski; Gabriella Sármay
Journal:  MAbs       Date:  2014-04-23       Impact factor: 5.857

Review 7.  Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors.

Authors:  Carol T Cady; Jeffrey S Rice; Vanessa L Ott; John C Cambier
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

Review 8.  Intersection of FcγRIIB, the microbiome, and checkpoint inhibitors in antitumor immunity.

Authors:  Kirsten M Baecher; Mandy L Ford
Journal:  Cancer Immunol Immunother       Date:  2021-07-09       Impact factor: 6.968

Review 9.  Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.

Authors:  Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

10.  Inhibitory Receptor Trap: A Platform for Discovery of Inhibitory Receptors That Utilize Inositol Lipid and Phosphotyrosine Phosphatase Effectors.

Authors:  Bergren W Crute; Rachel Sheraden; Vanessa L Ott; Isaac T W Harley; Andrew Getahun; John C Cambier
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.